POLISCOPE
Back to feed
NewsKPBS Public MediaOctober 28, 2026San Diego County

Department of Health and Human Services will allow small compounding pharmacies to produce popular peptides

Photo: KPBS Public Media

The Department of Health and Human Services announced it will exercise enforcement discretion allowing small compounding pharmacies to produce six popular peptides despite an official ban. The policy aims to provide a safer alternative to illicit online sellers, though smaller producers may struggle to meet consumer demand. Consumer advocacy groups have criticized the move, arguing it bypasses standard FDA drug review processes and threatens public health.

HealthPrescription DrugsFederal RegulationsPublic Health
Read the full story at KPBS Public Media

Why It Matters

Patients seeking specific will have legal access through small instead of relying on overseas gray-market suppliers, though production limits mean supply may fall short of demand.

Key Facts

  • The Department of Health and Human Services will exercise enforcement discretion for six peptides, allowing them to be made by small compounding pharmacies.
  • The policy applies exclusively to small 503A compounding pharmacies and does not apply to larger 503B outsourcing facilities.
  • The targeted peptides have not completed the Food and Drug Administration's standard drug review and approval process.
  • In July, an advisory panel to the Food and Drug Administration voted in favor of expanded access to six peptides through compounding, while agency scientists recommended against lifting restrictions.
  • Compounding pharmacy leaders warn that small facilities will likely struggle to meet consumer demand for the products.
  • Consumer advocacy groups like Public Citizen criticized the policy for circumventing the formal rulemaking process and undermining the Food and Drug Administration.
  • The Partnership for Safe Medicines filed a citizen petition urging the Food and Drug Administration to ignore the advisory committee's recommendation.

Who's Mentioned

OrganizationAlliance for Pharmacy Compounding“Professional association representing compounding pharmacies”PersonShabbir Safda“Executive director at Partnership for Safe Medicines”PersonDr. Robert Steinbrook“Health Research Group Director at Public Citizen”OrganizationPartnership for Safe Medicines“Organization including various pharmacy and pharmacist groups”PersonJoshua Fritzler“President of Olympia and Wesley Pharmaceuticals”PersonRobert F. Kennedy Jr.“Health Secretary and supporter of peptides”OrganizationPublic Citizen“Nonprofit consumer advocacy group”OrganizationDepartment of Health and Human Services“Issued the new policy regarding peptides”PersonScott Brunner“CEO of the Alliance for Pharmacy Compounding”OrganizationOlympia and Wesley Pharmaceuticals“A compounding pharmacy in central Florida”OrganizationFood and Drug Administration“Responsible for standard drug review and approval processes”